Trial · NCT05070897
Health Literacy and Digital Health in Cancer Patients.
NCT05070897, Completed, Institut Bergonié; results first posted 2024-04-12
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Health Literacy and Digital Health in Cancer Patients. Trials, record NCT05070897. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05070897
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Health Literacy and Digital Health in Cancer Patients.
- NCT number
- NCT05070897
- Status
- Completed
- Enrollment
- 1,518 participants, actual
- Lead sponsor
- Institut Bergonié
- Conditions
- Cancer
- Interventions
- Questionnaires
- First posted
- 2021-10-07
- Last updated
- 2024-06-12
- Results first posted
- 2024-04-12
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants With an Overall Score of ≤ 4 on the FCCHL Scale. | 1 month | Health literacy of cancer patients using the approved French version of the Functional, Communicative and Critical Health Literacy (FCCHL) scale. The FCCHL questionnaire includes 14 items, divided into 3 sub-scales, reflecting 3 health literacy skills (functional literacy, interactive literacy and critical literacy). The overall score will be calculated by determining the mean score for the 3 sub-scales. A score of ≤ 4 on the FCCHL scale, corresponds to a low level of health literacy. Each item of the FCCHL takes a score of 1 to 5 points. For each patient, a literacy score per sub-scale will be determined by calculating the number of points divided by the number of items on the sub-scale. The score can range from 1 to 5. The overall literacy score will be calculated as the mean of the 3 sub-scales. This score can range from 1 to 5. For functional scale, higher value represent worse outcome and for the other scale, a higher value represent a better outcome. |
| Secondary | Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | 1 month | The questionnaire on the use of digital tools will be described per item: * This questionnaire includes 10 items. * A Likert-type scale with five modalities of response is proposed (never, rarely, sometimes, often, always). * No overall score will be calculated. |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Participants With an Overall Score of ≤ 4 on the FCCHL Scale. | 1 month | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | 1 month | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group134
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With an Overall Score of ≤ 4 on the FCCHL Scale. | Population A | 518 | Participants | ||
| Percentage of Participants With an Overall Score of ≤ 4 on the FCCHL Scale. | Population B | 468 | Participants | ||
| Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | Population A | Use of internet / Never | 232 | Participants | |
| Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | Population B | Use of internet / Never | 39 | Participants | |
| Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | Population A | Use of internet / Rarely | 26 | Participants | |
| Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | Population B | Use of internet / Rarely | 17 | Participants | |
| Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | Population A | Use of internet / Sometimes | 64 | Participants | |
| Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | Population B | Use of internet / Sometimes | 43 | Participants | |
| Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | Population A | Use of internet / Often | 156 | Participants | |
| Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools. | Population B | Use of internet / Often | 133 | Participants |
1 to 10 of 134Source ClinicalTrials.gov
See all 134 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Population A | 781 | |
| Overall Study | STARTED | Population B | 737 | |
| Overall Study | COMPLETED | Population A | 658 | |
| Overall Study | COMPLETED | Population B | 669 | |
| Overall Study | NOT COMPLETED | Population A | 123 | |
| Overall Study | NOT COMPLETED | Population B | 68 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Population A | 0 | 0 |
| Total, all-cause mortality | Population B | 0 | 0 |
| Total, other adverse events | Population A | 0 | 0 |
| Total, other adverse events | Population B | 0 | 0 |
| Total, serious adverse events | Population A | 0 | 0 |
| Total, serious adverse events | Population B | 0 | 0 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Population A vs Population B: Percentage of Participants With an Overall Score of ≤ 4 on the FCCHL Scale. |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05070897
GET https://conductscience.org/api/trials/v1/NCT05070897/results?page=2